Skip to main content
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1990 Nov 1;172(5):1509–1512. doi: 10.1084/jem.172.5.1509

Widespread intradermal accumulation of mononuclear leukocytes in lepromatous leprosy patients treated systemically with recombinant interferon gamma

PMCID: PMC2188674  PMID: 2121891

Abstract

Intradermal administration of recombinant interferon gamma (rIFN-gamma) to lepromatous leprosy patients has converted the local histology toward a tuberculoid pattern. However, such changes have been confined to the site of injection. In contrast, in the present study, marked, intradermal accumulation of CD3+, CD4+, CD8+, and CD1a+ T cells and Leu- M5+ mononuclear phagocytes was induced at a distance from the sites of administration, in a dose-dependent manner, by 10 daily intramuscular injections of 10-30 micrograms rIFN-gamma/m2. Mononuclear cell infiltration began within 3 d of onset of rIFN-gamma therapy and persisted at least 8 wk. Intramuscular administration of rIFN-gamma to lepromatous patients receiving concurrent chemotherapy can safely induce widespread histologic features of an upgrading reaction.

Full Text

The Full Text of this article is available as a PDF (469.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Convit J., Pinardi M. E., Rodríguez Ochoa G., Ulrich M., Avila J. L., Goihman M. Elimination of Mycobacterium leprae subsequent to local in vivo activation of macrophages in lepromatous leprosy by other mycobacteria. Clin Exp Immunol. 1974 Jun;17(2):261–265. [PMC free article] [PubMed] [Google Scholar]
  2. Harms G., Zwingenberger K., Chéhadé A. K., Talhari S., Racz P., Mouakeh A., Douba M., Näkel L., Naiff R. D., Kremsner P. G. Effects of intradermal gamma-interferon in cutaneous leishmaniasis. Lancet. 1989 Jun 10;1(8650):1287–1292. doi: 10.1016/s0140-6736(89)92686-x. [DOI] [PubMed] [Google Scholar]
  3. Hastings R. C., Job C. K. Reversal reactions in lepromatous leprosy following transfer factor therapy. Am J Trop Med Hyg. 1978 Sep;27(5):995–1004. doi: 10.4269/ajtmh.1978.27.995. [DOI] [PubMed] [Google Scholar]
  4. Kaplan G., Mathur N. K., Job C. K., Nath I., Cohn Z. A. Effect of multiple interferon gamma injections on the disposal of Mycobacterium leprae. Proc Natl Acad Sci U S A. 1989 Oct;86(20):8073–8077. doi: 10.1073/pnas.86.20.8073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Kaplan G., Nusrat A., Sarno E. N., Job C. K., McElrath J., Porto J. A., Nathan C. F., Cohn Z. A. Cellular responses to the intradermal injection of recombinant human gamma-interferon in lepromatous leprosy patients. Am J Pathol. 1987 Aug;128(2):345–353. [PMC free article] [PubMed] [Google Scholar]
  6. Kaplan G., Sheftel G., Job C. K., Mathur N. K., Nath I., Cohn Z. A. Efficacy of a cell-mediated reaction to the purified protein derivative of tuberculin in the disposal of Mycobacterium leprae from human skin. Proc Natl Acad Sci U S A. 1988 Jul;85(14):5210–5214. doi: 10.1073/pnas.85.14.5210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Nathan C. F., Kaplan G., Levis W. R., Nusrat A., Witmer M. D., Sherwin S. A., Job C. K., Horowitz C. R., Steinman R. M., Cohn Z. A. Local and systemic effects of intradermal recombinant interferon-gamma in patients with lepromatous leprosy. N Engl J Med. 1986 Jul 3;315(1):6–15. doi: 10.1056/NEJM198607033150102. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES